142 related articles for article (PubMed ID: 9517521)
1. The symptomatic effect of cisapride in patients with irritable bowel syndrome and constipation.
Farup PG; Hovdenak N; Wetterhus S; Lange OJ; Hovde O; Trondstad R
Scand J Gastroenterol; 1998 Feb; 33(2):128-31. PubMed ID: 9517521
[TBL] [Abstract][Full Text] [Related]
2. Cisapride treatment of constipation-predominant irritable bowel syndrome is not superior to placebo.
Ziegenhagen DJ; Kruis W
J Gastroenterol Hepatol; 2004 Jul; 19(7):744-9. PubMed ID: 15209619
[TBL] [Abstract][Full Text] [Related]
3. Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome.
Schütze K; Brandstätter G; Dragosics B; Judmaier G; Hentschel E
Aliment Pharmacol Ther; 1997 Apr; 11(2):387-94. PubMed ID: 9146780
[TBL] [Abstract][Full Text] [Related]
4. Effects of cisapride on symptoms and postcibal small-bowel motor function in patients with irritable bowel syndrome.
Noor N; Small PK; Loudon MA; Hau C; Campbell FC
Scand J Gastroenterol; 1998 Jun; 33(6):605-11. PubMed ID: 9669632
[TBL] [Abstract][Full Text] [Related]
5. "Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride.
Van Outryve M; Milo R; Toussaint J; Van Eeghem P
J Clin Gastroenterol; 1991 Feb; 13(1):49-57. PubMed ID: 2007745
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral cisapride on small bowel motility in irritable bowel syndrome.
Evans PR; Bak YT; Kellow JE
Aliment Pharmacol Ther; 1997 Oct; 11(5):837-44. PubMed ID: 9354190
[TBL] [Abstract][Full Text] [Related]
7. Cisapride for intestinal constipation.
Aboumarzouk OM; Agarwal T; Antakia R; Shariff U; Nelson RL
Cochrane Database Syst Rev; 2011 Jan; (1):CD007780. PubMed ID: 21249695
[TBL] [Abstract][Full Text] [Related]
8. Use of cisapride in treatment of constipation in children.
Odeka EB; Sagher F; Miller V; Doig C
J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):199-203. PubMed ID: 9252908
[TBL] [Abstract][Full Text] [Related]
9. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
Evans BW; Clark WK; Moore DJ; Whorwell PJ
Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic constipation with cisapride and placebo.
Müller-Lissner SA
Gut; 1987 Aug; 28(8):1033-8. PubMed ID: 3311905
[TBL] [Abstract][Full Text] [Related]
12. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM
Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
[TBL] [Abstract][Full Text] [Related]
13. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
Videlock EJ; Cheng V; Cremonini F
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
[TBL] [Abstract][Full Text] [Related]
14. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
Champion MC; MacCannell KL; Thomson AB; Tanton R; Eberhard S; Sullivan SN; Archambault A
Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
[TBL] [Abstract][Full Text] [Related]
15. Cisapride in chronic idiopathic constipation: clinical response and effect on colonic transit time.
Bak YT; Kim JH; Lee CH
Korean J Intern Med; 1996 Jun; 11(2):151-6. PubMed ID: 8854652
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation.
Novick J; Miner P; Krause R; Glebas K; Bliesath H; Ligozio G; Rüegg P; Lefkowitz M
Aliment Pharmacol Ther; 2002 Nov; 16(11):1877-88. PubMed ID: 12390096
[TBL] [Abstract][Full Text] [Related]
17. Cisapride for the treatment of constipation in children: A double-blind study.
Nurko S; Garcia-Aranda JA; Worona LB; Zlochisty O
J Pediatr; 2000 Jan; 136(1):35-40. PubMed ID: 10636971
[TBL] [Abstract][Full Text] [Related]
18. Effect of cisapride on chronic idiopathic constipation in children.
Staiano A; Cucchiara S; Andreotti MR; Minella R; Manzi G
Dig Dis Sci; 1991 Jun; 36(6):733-6. PubMed ID: 2032513
[TBL] [Abstract][Full Text] [Related]
19. [A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of tegaserod in Chinese patients with constipation-predominant irritable bowel syndrome].
Tegaserod Clinical Research Group
Zhonghua Nei Ke Za Zhi; 2003 Feb; 42(2):88-90. PubMed ID: 12783702
[TBL] [Abstract][Full Text] [Related]
20. Tegaserod: a review of its use in the management of irritable bowel syndrome with constipation in women.
Wagstaff AJ; Frampton JE; Croom KF
Drugs; 2003; 63(11):1101-20. PubMed ID: 12749744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
